Innovation boundaries in the field of artificial intelligence are being continuously redefined. Known for creative image generation, Midjourney has recently officially announced its entry into the medical imaging market, launching its first hardware product—a full-body scanner based on ultrasound technology. This move marks the company's attempt to extend AI computing power from simple image generation to quantitative perception of human anatomy.

The device, named "Midjourney Scanner," features a highly technological design. It uses a ring sensor array and, through deep collaboration with ultrasound technology company Butterfly Network, integrates 40 imaging modules. Its working principle is similar to "echolocation." Users need only stand in a shallow pool, and the device will slowly pass over the body, emitting and receiving echo signals through thousands of transducers. According to official statements, a complete full-body check takes only 60 seconds, generating high-precision three-dimensional cross-sectional images covering muscles, fat, bones, and some organs.

Game character AI painting (1) Anime

Regarding the application vision of this product, CEO David Holz expressed strong enthusiasm. He hopes that this non-ionizing radiation and non-magnetic convenient method can make medical imaging as common as routine physical exams, even envisioning that users could frequently scan their bodies to quantitatively track changes caused by diet and exercise. To turn this vision into a physical experience, Midjourney plans to open an offline space in San Francisco's Union Square, integrating scanning, fitness, and spa services, expected to be open to the public by the end of 2027.

On the technical implementation side, the device's backend computing power reaches up to 2 PFLOPS. However, it remains unclear whether there is a deep connection between this system and Midjourney's original AI image generation models. The outside world generally views it as a strategic attempt by the company to utilize idle computing power and seek new growth points.

Crossing into the medical field, however, is not without challenges. Midjourney currently emphasizes that the device focuses on "body composition maps" that do not involve clinical diagnosis, to avoid complex compliance procedures. However, if the scan results are to be formally used for disease diagnosis, they still need to go through strict FDA approval. Holz admitted that this concept is still far from large-scale implementation, and the company will further improve data policies and continuously optimize related technologies and clinical pathways. From a creative brush to medical imaging, Midjourney's cross-industry experiment may be opening a new chapter in personal health management.